rxstat › Shortages › Dapagliflozin
Dapagliflozin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Dapagliflozin products are in shortage in Canada (4 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 24, 2026.
In shortage since
Dec 9, 2025
Est. full return
Jul 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · since Jun 9, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-DAPAGLIFLOZIN
5MG · TABLET · APOTEX INC
DIN 02527189 · since Jan 27, 2026, est. end May 15, 2026 · Disruption of the manufacture of the drug.
Active shortageGLN-DAPAGLIFLOZIN
10MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519860 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortageGLN-DAPAGLIFLOZIN
5MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02519852 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
ResolvedAPO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended May 22, 2026 · Disruption of the manufacture of the drug.
ResolvedJAMP DAPAGLIFLOZIN
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02531372 · ended Apr 7, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-DAPAGLIFLOZIN
10MG · TABLET · APOTEX INC
DIN 02527197 · ended Nov 27, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ DAPAGLIFLOZIN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02518740 · ended May 26, 2025 · Delay in shipping of the drug.
ResolvedPMS-DAPAGLIFLOZIN
5MG · TABLET · PHARMASCIENCE INC
DIN 02531550 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
ResolvedAURO-DAPAGLIFLOZIN
5MG · TABLET · AURO PHARMA INC
DIN 02531402 · ended Jan 31, 2025 · Demand increase for the drug.
ResolvedAURO-DAPAGLIFLOZIN
10MG · TABLET · AURO PHARMA INC
DIN 02531410 · ended Jan 28, 2025 · Demand increase for the drug.
ResolvedSANDOZ DAPAGLIFLOZIN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02518740 · ended Aug 12, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Dapagliflozin is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, GLENMARK PHARMACEUTICALS CANADA INC..
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Dapagliflozin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BK).
Recent changes
Common questions
When will Dapagliflozin be back in stock in Canada?
The latest manufacturer estimate is Jul 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Dapagliflozin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All blood glucose lowering drugs, excl. insulins shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.